Cabaletta Bio Inc is a distinguished player in the biotechnology world, developing cellular therapies for patients suffering from autoimmune diseases. The firm operates on a global level.
Cabaletta Bio operates in the groundbreaking and fast-paced biotechnology industry. It is known for its innovative services, particularly its cellular therapies based on the revolutionary Chimeric AutoAntibody Receptor (CAAR) platform. While it is part of the larger community of biotech firms, it sets the tone in its unique domain of autoimmune diseases with its scientifically advanced approach.
Expand your virtual portfolio by following CABA on eToro.